COVID-19 Vaccines: Myocarditis Reports Could Slow Expansion Into Pediatric Age Groups

 
• By Sue Sutter

Concerns about cases of heart muscle inflammation occurring in older male adolescents and young men shortly after the second dose of Pfizer and Moderna mRNA vaccines hung over FDA advisory committee discussions on pediatric safety data requirements for COVID-19 vaccines; CDC’s ACIP will take up the myocarditis issue at an 18 June meeting.

Tip of the iceberg
One FDA panelist worries the reports of myocarditis following mRNA vaccination are just the tip of the iceberg. • Source: Alamy

More from Vaccines

More from Pink Sheet